Presentations
April 5, 2011
TetraLogic Pharmaceuticals presents Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma at the 102nd Annual Meeting of the American Association for Cancer Research in Orlando, FL.
For a copy of the presentation, click here.